Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Alstom SA ( (FR:ALO) ).
Alstom has secured a CAD 2.3 billion contract with the Toronto Transit Commission to supply 70 six-car Metropolis New Subway Trains, primarily to replace the aging fleet on Line 2 and to serve upcoming extensions of Lines 1 and 2. The trains, which feature open gangways, enhanced accessibility, energy-efficient systems, advanced cybersecurity and eco-design elements, will be designed and engineered in Canada, assembled in Thunder Bay and tested in Kingston, creating up to 945 direct and over 1,700 indirect jobs nationwide. By investing in local production capabilities and relying on Canadian materials and suppliers, the agreement strengthens Canada’s rail manufacturing base, supports government objectives to modernise Toronto’s growing subway system and reinforces domestic resilience against global trade disruptions, while bolstering Alstom’s position in the North American urban transit market.
The most recent analyst rating on (FR:ALO) stock is a Hold with a EUR27.00 price target. To see the full list of analyst forecasts on Alstom SA stock, see the FR:ALO Stock Forecast page.
More about Alstom SA
Alstom SA is a global leader in smart and sustainable mobility solutions, specialising in the design and manufacture of rail transport equipment such as metro trains, with a strong presence in Canada as a national champion in rail manufacturing and innovation. Its Metropolis metro platform serves urban transit networks worldwide, focusing on energy efficiency, adaptability to existing infrastructure and support for local industrial ecosystems through domestic engineering, production and supply chains.
Average Trading Volume: 1,000,516
Technical Sentiment Signal: Buy
Current Market Cap: €11.96B
See more insights into ALO stock on TipRanks’ Stock Analysis page.

